PHYTOMAB
LIVE

Serial Number

79313411

Owner

PHYTOMAB CO., LTD.

Attorney

Kisuk Lee

Filing Date

Apr 6, 2021

Add to watchlist:

No watchlists yet
View on USPTO

PHYTOMAB Trademark

Serial Number: 79313411 • Registration: 6810859

PHYTOMAB is a trademark filed by PHYTOMAB CO., LTD. on April 6, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

PHYTOMAB CO., LTD. (2 trademarks)

#606-297, 18, Maebongsan-ro,

Entity Type: 99

Trademark Details

Filing Date

April 6, 2021

Registration Date

August 9, 2022

Published for Opposition

May 24, 2022

Goods & Services

Medicines for the treatment of cancer, namely, anticancer medicines; biological preparations for medical, pharmaceutical and veterinary purposes, namely, biological preparations for treatment of cancer; proteins for medical, pharmaceutical and veterinary purposes, namely, protein arrays for medical diagnosis purposes; biological vectors for medical, pharmaceutical and veterinary purposes, namely, viral vectors for treatment of cancer; [ preparations of transformation microorganisms for medical, pharmaceutical and veterinary purposes, namely, for the treatment of cancer; preparations of microorganisms for medical, pharmaceutical and veterinary purposes used for enhancing biomolecule production for treating cancer; ] preparations of gene recombination for medical, pharmaceutical and veterinary purposes used for biomolecule production for treating cancer; recombinant cells for medical, pharmaceutical and veterinary purposes; cell lines for medical, pharmaceutical and veterinary purposes; medical, pharmaceutical and veterinary preparations for the treatment of cells; stem cells for medical, pharmaceutical and veterinary purposes; vaccines for medical, pharmaceutical and veterinary purposes; antibiotics for medical, pharmaceutical and veterinary purposes; anti-cancer preparations for medical, pharmaceutical and veterinary purposes; nucleic acid sequences for medical, pharmaceutical and veterinary purposes; biopharmaceuticals for treatment of hepatitis; biopharmaceuticals for the treatment of cancer; biopharmaceuticals for the treatment of auto-immune diseases

[ pharmaceutical research and development; ] chemistry services, namely, chemical analysis; synthetic biology services, namely, research and analysis in the field of synthetic biology; stem cells biology services, namely, research and analysis in the field of stem cell biology; Stem cell research services; drug discovery services using plant cells; drug discovery services using stem cells; development services of new pharmaceutical products; [ laboratory research services relating to pharmaceuticals; ] testing of pharmaceuticals; medical research; biotechnological research; biological research; chemical research; research and development services relating to genetic testing; research and development services relating to medical, pharmacological and veterinary science; laboratory research in the field of pharmaceuticals, biology, biochemistry and chemistry; research and development services in the field of [ microorganisms and ] cells technology; research services in the field of chemistry, biochemistry, enzymology, biology, cell biology and biotechnology

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jan 13, 2024 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 3, 2024 INPR
NEW REPRESENTATIVE AT IB RECEIVED
Jun 9, 2023 NREP
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Jun 6, 2023 NURC
LIMITATION FROM THE IB EXAMINED AND ENTERED
May 3, 2023 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
May 3, 2023 COC.
LIMITATION OF GOODS RECEIVED FROM IB
Feb 6, 2023 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 12, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 18, 2022 FICS
FINAL DISPOSITION PROCESSED
Nov 18, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 9, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 9, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 9, 2022 R.PR
NOTIFICATION PROCESSED BY IB
May 24, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 24, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 24, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 4, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 4, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 4, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 16, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 6, 2022 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 6, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 6, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 6, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 6, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 6, 2022 COAR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 6, 2022 TROA
REFUSAL PROCESSED BY IB
Jan 15, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 27, 2021 RFCS
REFUSAL PROCESSED BY MPU
Dec 27, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 30, 2021 RFCR
NON-FINAL ACTION WRITTEN
Nov 29, 2021 CNRT
ASSIGNED TO EXAMINER
Nov 22, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 26, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 22, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 17, 2021 REPR